BioMarker Strategies
About:
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer.
Website: http://www.biomarkerstrategies.com
Description:
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer. BioMarker Strategies is a tissue-based cancer diagnostics company. It was founded in 2006 and is headquartered in Baltimore, Maryland.
Total Funding Amount:
$5.7M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Baltimore, Maryland, United States
Founded Date:
2006-01-01
Contact Email:
info(AT)biomarkerstrategies.com
Founders:
Douglas P. Clark, Jack Davis, Scott Allocco
Number of Employees:
11-50
Last Funding Date:
2016-09-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai